NDA 010040 · Bracco
Renografin-76
Diatrizoate Meglumine, Diatrizoate Sodium · Injection, Urethral, Ureteral
Last checked: Nov 19, 2026Latest source record: Jul 6, 2015 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
1955
Aug 2, 1955
Approved uses
4
Original approval plus efficacy supplements
Registered trials
14
4 Phase 3, 1 recruiting
FAERS reports
158
144 serious, 96 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
From the label in effect Nov 23, 2025.
INDICATION Cystografin is indicated for retrograde cystourethrography.
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Apr 3, 1984 Supplement 143 · Efficacy
- Jul 10, 1983 Supplement 107 · Efficacy
- Sep 27, 1982 Supplement 121 · Efficacy
- Aug 2, 1955 Original approval · Type 2 New Active Ingredient and Type 4 New Combination
10 products under this application
- RENOGRAFIN-76 · DIATRIZOATE MEGLUMINE 66%; DIATRIZOATE SODIUM 10% · INJECTABLE, INJECTION · Discontinued
- CYSTOGRAFIN · DIATRIZOATE MEGLUMINE 30% · SOLUTION, URETHRAL · Prescription
- RENO-60 · DIATRIZOATE MEGLUMINE 60% · INJECTABLE, INJECTION · Discontinued
- CYSTOGRAFIN DILUTE · DIATRIZOATE MEGLUMINE 18% · SOLUTION, URETHRAL · Prescription
- RENOGRAFIN-60 · DIATRIZOATE MEGLUMINE 52%; DIATRIZOATE SODIUM 8% · INJECTABLE, INJECTION · Discontinued
- RENOVIST · DIATRIZOATE MEGLUMINE 34.3%; DIATRIZOATE SODIUM 35% · INJECTABLE, INJECTION · Discontinued
- RENO-DIP · DIATRIZOATE MEGLUMINE 30% · INJECTABLE, INJECTION · Discontinued
- RENOVIST II · DIATRIZOATE MEGLUMINE 28.5%; DIATRIZOATE SODIUM 29.1% · INJECTABLE, INJECTION · Discontinued
- DIATRIZOATE MEGLUMINE · DIATRIZOATE MEGLUMINE 76% · INJECTABLE, INJECTION · Discontinued
- RENO-30 · DIATRIZOATE MEGLUMINE 30% · SOLUTION, URETERAL · Discontinued
Clinical trials
Interventional ClinicalTrials.gov studies with "Diatrizoate Meglumine" as an intervention, any sponsor and status, largest first.
- Topical Pancreatic Duct Lidocaine for Prevention of Post-ERCP PancreatitisPivotal-lookingCompleted
Abraham Mathew MDAcademic, hospital or other
NCT00953199 · 506 participants · Start Mar 2010 · Primary completion May 2013
Drug: Lidocaine Hydrochloride; Normal Saline · For: Pancreatitis
Sites: Hershey, Pennsylvania
- Omnipaque Versus Gastroview as Oral Contrast for Abdominal and Pelvic CTPivotal-lookingCompleted
University of Alabama at BirminghamAcademic, hospital or other
NCT00478556 · 300 participants · Start Aug 2007 · Primary completion Mar 2009
Drug: Omnipaque; Gastroview · For: Healthy
Sites: Birmingham, Alabama
- Value of CT-Scan and Oral Gastrografin in the Management of Post Operative Small Bowel ObstructionPivotal-lookingCompleted
University Hospital, RouenAcademic, hospital or other
NCT00389116 · 242 participants · Start Nov 2006 · Primary completion Aug 2009
Drug: gastrograffin; water · For: Small Bowel Obstruction
Sites: Rouen, France
- Bowel Preparation Regimen for Colon Capsule Endoscopy ProcedurePivotal-lookingCompleted
Region SkaneAcademic, hospital or other
NCT05726097 · 147 participants · Start Feb 1, 2023 · Primary completion Oct 31, 2023
Drug: polyethylene glycol; sodium phosphate and 4 more · For: Colon Cancer; Inflammatory Bowel Diseases; Gastrointestinal Bleed and 1 more
Sites: Malmö, Sweden
- Optimization of the Bowel Preparation Regimen for the PillCam® COLON 2 Capsule Endoscopy ProcedurePivotal-lookingCompleted
Medtronic - MITGIndustry
NCT02481219 · 122 participants · Start May 2015 · Primary completion Jan 2016
Drug: Senna tablets; PEG and 5 more · For: Colorectal Cancer Screening
Sites: Anniston, Alabama; Indianapolis, Indiana; Dayton, Ohio · 6 sites in all
- Fluorescence Cholangiography During Cholecystectomy - a RCTPivotal-lookingCompleted
Hvidovre University HospitalAcademic, hospital or other
NCT02344654 · 120 participants · Start May 1, 2015 · Primary completion Aug 27, 2018
Drug: Indocyanine green; Urografin · For: Cholecystitis; Gallstones
Jinling Hospital, ChinaAcademic, hospital or other
NCT03642288 · 112 participants · Start Apr 1, 2014 · Primary completion Jun 30, 2018
Drug: Gastrografin · For: CRE-induced SBO
Nadja Haiden,MDAcademic, hospital or other
NCT01515696 · 96 participants · Start Oct 2007 · Primary completion Oct 2010
Drug: Gastrografin; Sterile water · For: Meconium Ileus; Very Low Birth Weight Infant
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
- off label use85
- drug ineffective78
- nausea75
- pain73
- rash72
- confusional state71
- dyspnoea71
- treatment failure71
- wound71
- therapeutic product effect decreased70
- pericarditis69
- psoriatic arthropathy69
FAERS reports by year
By the date FDA received the report.
View as table
| Year | Reports |
|---|---|
| 2004 | 1 |
| 2005 | 4 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 6 |
| 2020 | 8 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 8 |
| 2024 | 20 |
| 2025 | 59 |
| 2026 | 23 |
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Prevention of pericardial constriction by transcatheter intrapericardial fibrinolysis with urokinase.
Cui HB, Chen XY, Cui CC, et al. · Chin Med Sci J 2005 · Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Effect of intracoronary injections of sonicated microbubbles on left ventricular contractility.
Lang RM, Borow KM, Neumann A, et al. · Am J Cardiol 1987 · Clinical Trial, Comparative Study
- Multicenter, randomized study to optimize bowel preparation for colon capsule endoscopy.
Kastenberg D, Burch WC, Romeo DP, et al. · World J Gastroenterol 2017 · Equivalence Trial, Multicenter Study
- Iohexol: a new, nonionic agent in adult peripheral arteriography.
Roy P, Robillard P, L'Homme C, et al. · J Can Assoc Radiol 1985 · Clinical Trial, Comparative Study
- Double-blind comparison of Hexabrix and Renografin-76 in computed tomography.
Berland LL · Invest Radiol 1984 · Clinical Trial, Comparative Study
- A double-blind clinical comparison of Hexabrix and Renografin-76 for intravenous digital subtraction angiography.
Turski PA, Gentry LR, Matozzi F, et al. · Invest Radiol 1984 · Clinical Trial, Comparative Study
Sponsor: Bracco · Also marketed as Cystografin, Reno-60, Cystografin Dilute, Renografin-60, Renovist
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.